Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 2Completed 1

Sponsor Class

OTHER 112INDUSTRY 47NETWORK 6NIH 3OTHER_GOV 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 2Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 3Rectal Neoplasms 2Colonic Neoplasms 1

Interventions

Fluorouracil 126Leucovorin 90Oxaliplatin 82Specimen Handling 71Gemcitabine 61Magnetic Resonance Spectroscopy 55Irinotecan 55Biopsy 53Capecitabine 40Bevacizumab 40Radiotherapy 37Cisplatin 34Cetuximab 29Chemotherapy, Adjuvant 28Erlotinib Hydrochloride 26Neoadjuvant Therapy 21dehydroftorafur 20Cyclophosphamide 19Nivolumab 18Sorafenib 17Radiation 17Paclitaxel 17X-Rays 16Doxorubicin 16aldesleukin 14Immunoglobulin G 14Disulfides 14fludarabine 13Folfox protocol 13Carboplatin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Panitumumab × Gastrointestinal × Clear all
NCT03366155 2026-01-08

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
24 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00967655 2014-01-10

Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
54 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT01110785 2013-09-17

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
46 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡